ESR1 and breast carcinoma: We elucidate distinct gene expression profiles of tumor cells in unpaired primary and metastatic ER+ breast cancer samples while identifying specific subtypes of stromal and immune cells that may collectively contribute to developing an immunosuppressive microenvironment within metastatic tumors.